Barclays Reiterates Rating on Corteva, Inc. $CTVA
Key Points
- Barclays now rates Corteva, Inc. ($CTVA) "buy" with a $91.00 target.
- The Street's average $CTVA price target is $90.05 (Buy).
- $CTVA last traded around $76.14.
Barclays reiterated its rating on Corteva, Inc. ($CTVA) to a "buy" rating, with a price target of $91.00 in a recent research note.
Corteva, Inc. ($CTVA) Stock
Corteva, Inc. Earnings
Corteva, Inc. Dividend
Analysts Set New Price Targets
About Corteva, Inc.
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.